{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:37:58Z","timestamp":1794559078336,"version":"4.9.1"},"reference-count":49,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3,16]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>The systematic review suggests that first-line antenatal management in FNAIT is weekly IVIG administration. Noninvasive management is effective without the relatively high rate of adverse outcomes seen in invasive strategies.<\/jats:p>","DOI":"10.1182\/blood-2016-10-739656","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T20:25:23Z","timestamp":1485548723000},"page":"1538-1547","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":136,"title":["Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review"],"prefix":"10.1182","volume":"129","author":[{"given":"Dian","family":"Winkelhorst","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Blood Transfusion Medicine, Oxford University Hospitals, and"},{"name":"NHS Blood and Transplant, University of Oxford, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Greinacher","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Transfusion Medicine, University Hospital Greifswald, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Shehata","sequence":"additional","affiliation":[{"name":"Department of Medicine, and"},{"name":"Department of Obstetric Medicine, Mount Sinai Hospital, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taman","family":"Bakchoul","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Transfusion Medicine, University Hospital Greifswald, Greifswald, Germany;"},{"name":"Center for Clinical Transfusion Medicine, University of Tuebingen, Tuebingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Massey","sequence":"additional","affiliation":[{"name":"Diagnostic and Therapeutic Services, NHS Blood and Transplant, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Baker","sequence":"additional","affiliation":[{"name":"Hospital for Sick Children, St. Michael\u2019s Hospital, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lani","family":"Lieberman","sequence":"additional","affiliation":[{"name":"University Health Network, University of Toronto, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susano","family":"Tanael","sequence":"additional","affiliation":[{"name":"Center for Innovation, Canadian Blood Services, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Hume","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, QC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Division of Hematology and Thromboembolism, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoma","family":"Baidya","sequence":"additional","affiliation":[{"name":"Australian Red Cross Blood Service, Brisbane, QLD, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Bertrand","sequence":"additional","affiliation":[{"name":"Platelet Immunology Department, French Blood Services of Brittany, Rennes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bussel","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, Cornell University, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Kjaer","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Diagnostic Clinic, University Hospital of North Norway, Troms\u00f8, Norway;"},{"name":"Finnmark Hospital Trust, Hammerfest, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Institut National de la Transfusion Sanguine, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kjeldsen-Kragh","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Transfusion Medicine, Regional and University Laboratories, Region Sk\u00e5ne, Lund, Sweden; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Oepkes","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Ryan","sequence":"additional","affiliation":[{"name":"Fetal Medicine Unit, Mount Sinai Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"8","key":"2019111905125272800_B1","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1537-2995.2004.04026.x","article-title":"Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia","volume":"44","author":"Davoren","year":"2004","journal-title":"Transfusion"},{"issue":"8634","key":"2019111905125272800_B2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(89)91733-9","article-title":"348 cases of suspected neonatal alloimmune thrombocytopenia","volume":"1","author":"Mueller-Eckhardt","year":"1989","journal-title":"Lancet"},{"issue":"4","key":"2019111905125272800_B3","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI77820","article-title":"Maternal anti-platelet \u03b23 integrins impair angiogenesis and cause intracranial hemorrhage","volume":"125","author":"Yougbar\u00e9","year":"2015","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111905125272800_B4","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/trf.13550","article-title":"Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature","volume":"56","author":"Winkelhorst","year":"2016","journal-title":"Transfusion"},{"issue":"10","key":"2019111905125272800_B5","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2014-11-611020","article-title":"Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies","volume":"126","author":"Liu","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2019111905125272800_B6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.1980.tb08719.x","article-title":"Immune complexes in thrombocytopenic patients: cause or effect?","volume":"44","author":"Trent","year":"1980","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111905125272800_B7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1423-0410.2003.00302.x","article-title":"Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?","volume":"84","author":"Radder","year":"2003","journal-title":"Vox Sang"},{"issue":"8403","key":"2019111905125272800_B8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(84)90614-7","article-title":"Prenatal treatment of alloimmune thrombocytopenia","volume":"2","author":"Daffos","year":"1984","journal-title":"Lancet"},{"issue":"4","key":"2019111905125272800_B9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1067\/mob.2002.122140","article-title":"Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome","volume":"186","author":"Overton","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"21","key":"2019111905125272800_B10","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM198811243192103","article-title":"Antenatal treatment of neonatal alloimmune thrombocytopenia","volume":"319","author":"Bussel","year":"1988","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111905125272800_B11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/11537660-000000000-00000","article-title":"Relevant criteria for selecting an intravenous immunoglobulin preparation for clinical use","volume":"24","author":"Ch\u00e9rin","year":"2010","journal-title":"BioDrugs"},{"issue":"11","key":"2019111905125272800_B12","first-page":"1783","article-title":"Effects of antepartum therapy for fetal alloimmune thrombocytopenia on maternal lifestyle","volume":"29","author":"Rossi","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"7","key":"2019111905125272800_B13","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2019111905125272800_B14","unstructured":"Higgins\n              JPT\n            , AltmanDG, SterneJAC. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. London, United Kingdom: The Cochrane Collaboration; 2011. Available at: http:\/\/handbook.cochrane.org. Accessed 2 August 2016."},{"key":"2019111905125272800_B15","unstructured":"Wells\n              GA\n            , SheaB, O\u2019ConnellD, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Available at: www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 1 April 2016."},{"issue":"5","key":"2019111905125272800_B16","first-page":"CD004226","article-title":"Antenatal interventions for fetomaternal alloimmune thrombocytopenia","author":"Rayment","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2019111905125272800_B17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000089048","article-title":"Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage","volume":"21","author":"Kanhai","year":"2006","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"2019111905125272800_B18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.earlhumdev.2004.05.007","article-title":"Follow up of children after antenatal treatment for alloimmune thrombocytopenia","volume":"80","author":"Radder","year":"2004","journal-title":"Early Hum Dev"},{"issue":"2","key":"2019111905125272800_B19","doi-asserted-by":"crossref","first-page":"135.e1","DOI":"10.1016\/j.ajog.2010.03.011","article-title":"Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus","volume":"203","author":"Bussel","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2019111905125272800_B20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0002-9378(96)70582-3","article-title":"Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin","volume":"174","author":"Bussel","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2019111905125272800_B21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1423-0410.2010.01367.x","article-title":"Repeated intrauterine IgG infusions in foetal alloimmune thrombocytopenia do not increase foetal platelet counts","volume":"99","author":"Giers","year":"2010","journal-title":"Vox Sang"},{"issue":"1","key":"2019111905125272800_B22","first-page":"67","article-title":"Antenatal treatment of alloimmune thrombocytopenia","volume":"80","author":"Lynch","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2019111905125272800_B23","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1067\/mob.2000.104841","article-title":"Neonatal alloimmune thrombocytopenia: antenatal management","volume":"182","author":"Silver","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2019111905125272800_B24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3109\/14767058.2010.511333","article-title":"Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?","volume":"24","author":"Mechoulan","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"2019111905125272800_B25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood.V72.1.340.340","article-title":"Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets","volume":"72","author":"Kaplan","year":"1988","journal-title":"Blood"},{"issue":"10","key":"2019111905125272800_B26","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00431-006-0389-4","article-title":"Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG","volume":"166","author":"te Pas","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"9","key":"2019111905125272800_B27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1034\/j.1600-0412.2003.00188.x","article-title":"Experiences with fetomaternal alloimmune thrombocytopenia at a Swedish hospital over a 10-year period","volume":"82","author":"Tiblad","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"2019111905125272800_B28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2141.2003.04408.x","article-title":"European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia","volume":"122","author":"Birchall","year":"2003","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111905125272800_B29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2141.1998.00533.x","article-title":"Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids--more questions than answers","volume":"100","author":"Kaplan","year":"1998","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111905125272800_B30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000380907","article-title":"Low-dose versus standard-dose intravenous immunoglobulin to prevent fetal intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia: a randomized trial","volume":"38","author":"Paridaans","year":"2015","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"2019111905125272800_B31","first-page":"66","article-title":"Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin","volume":"13","author":"Van Der Lugt","year":"2015","journal-title":"Blood Transfus"},{"issue":"11","key":"2019111905125272800_B32","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1182\/blood-2010-08-302463","article-title":"Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia","volume":"117","author":"Bertrand","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111905125272800_B33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000264304","article-title":"Antenatal invasive and noninvasive management of alloimmune thrombocytopenia","volume":"11","author":"Kornfeld","year":"1996","journal-title":"Fetal Diagn Ther"},{"issue":"4","key":"2019111905125272800_B34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1471-0528.2007.01244.x","article-title":"Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective","volume":"114","author":"van den Akker","year":"2007","journal-title":"BJOG"},{"issue":"1","key":"2019111905125272800_B35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.AOG.0000192404.25780.68","article-title":"Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia","volume":"107","author":"Berkowitz","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"3 Pt 1","key":"2019111905125272800_B36","first-page":"433","article-title":"Antenatal treatment of fetal alloimmune thrombocytopenia","volume":"80","author":"Wenstrom","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"2 Pt 1","key":"2019111905125272800_B37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.AOG.0000270302.80336.dd","article-title":"Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial","volume":"110","author":"Berkowitz","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2019111905125272800_B38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajog.2006.06.066","article-title":"Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage","volume":"195","author":"Yinon","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2019111905125272800_B39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1538-7836.2006.01809.x","article-title":"Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia","volume":"4","author":"Bertrand","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111905125272800_B40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-3148.1994.tb00265.x","article-title":"Antenatal management of fetomaternal alloimmune thrombocytopenia--report of 15 affected pregnancies","volume":"4","author":"Murphy","year":"1994","journal-title":"Transfus Med"},{"issue":"5","key":"2019111905125272800_B41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1537-2995.2007.01208.x","article-title":"Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"issue":"4","key":"2019111905125272800_B42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-3148.1999.00216.x","article-title":"Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia","volume":"9","author":"Sainio","year":"1999","journal-title":"Transfus Med"},{"issue":"2 Pt 1","key":"2019111905125272800_B43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0002-9378(95)90559-6","article-title":"Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis","volume":"172","author":"Paidas","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2019111905125272800_B44","doi-asserted-by":"crossref","first-page":"e002490","DOI":"10.1136\/bmjopen-2012-002490","article-title":"Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry","volume":"3","author":"Tiller","year":"2013","journal-title":"BMJ Open"},{"issue":"3","key":"2019111905125272800_B45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molimm.2008.10.015","article-title":"HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity","volume":"46","author":"van Gils","year":"2009","journal-title":"Mol Immunol"},{"issue":"8","key":"2019111905125272800_B46","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/ATVBAHA.116.307281","article-title":"Antiendothelial \u03b1v\u03b23 antibodies are a major cause of intracranial bleeding in fetal\/neonatal alloimmune thrombocytopenia","volume":"36","author":"Santoso","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019111905125272800_B47","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume-title":"Clin Dev Immunol","author":"Palmeira","year":"2012"},{"issue":"3","key":"2019111905125272800_B48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1067\/mob.2001.116727","article-title":"A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia","volume":"185","author":"Radder","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2019111905125272800_B49","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00043426-198624000-00008","article-title":"In utero cerebral hemorrhage in alloimmune thrombocytopenia","volume":"8","author":"Herman","year":"1986","journal-title":"Am J Pediatr Hematol Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/11\/1538\/1399320\/blood739656.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/11\/1538\/1399320\/blood739656.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T05:13:20Z","timestamp":1574140400000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/11\/1538\/35953\/Antenatal-management-in-fetal-and-neonatal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,3,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-10-739656","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]}}}